CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q3 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $10,906,000 | +685.2% | 211,078 | +276.5% | 0.00% | – |
| Q2 2022 | $1,389,000 | -53.3% | 56,060 | -52.7% | 0.00% | – |
| Q1 2022 | $2,974,000 | +83.4% | 118,636 | +166.4% | 0.00% | – |
| Q4 2021 | $1,622,000 | +100.5% | 44,535 | -5.9% | 0.00% | – |
| Q3 2021 | $809,000 | +26.0% | 47,335 | -1.2% | 0.00% | – |
| Q2 2021 | $642,000 | -71.1% | 47,931 | +10.4% | 0.00% | – |
| Q1 2021 | $2,224,000 | -17.8% | 43,404 | -0.7% | 0.00% | – |
| Q4 2020 | $2,705,000 | +170.8% | 43,689 | +134.3% | 0.00% | – |
| Q3 2020 | $999,000 | +14.2% | 18,646 | +22.6% | 0.00% | – |
| Q2 2020 | $875,000 | +62.0% | 15,206 | +13.2% | 0.00% | – |
| Q1 2020 | $540,000 | +4.2% | 13,435 | +2.5% | 0.00% | – |
| Q4 2019 | $518,000 | +469.2% | 13,105 | -1.9% | 0.00% | – |
| Q3 2019 | $91,000 | -9.0% | 13,357 | +19.4% | 0.00% | – |
| Q2 2019 | $100,000 | +31.6% | 11,191 | +104.2% | 0.00% | – |
| Q1 2019 | $76,000 | +20.6% | 5,481 | -4.5% | 0.00% | – |
| Q4 2018 | $63,000 | -4.5% | 5,738 | +10.3% | 0.00% | – |
| Q3 2018 | $66,000 | -97.5% | 5,203 | -97.4% | 0.00% | -100.0% |
| Q2 2018 | $2,597,000 | +181.4% | 197,230 | +190.6% | 0.00% | – |
| Q1 2018 | $923,000 | +762.6% | 67,861 | +278.8% | 0.00% | – |
| Q4 2017 | $107,000 | +2.9% | 17,917 | +61.5% | 0.00% | – |
| Q2 2017 | $104,000 | -56.8% | 11,097 | -65.9% | 0.00% | – |
| Q4 2016 | $241,000 | +12.1% | 32,538 | -62.3% | 0.00% | – |
| Q1 2016 | $215,000 | -67.7% | 86,218 | +4.8% | 0.00% | – |
| Q4 2015 | $666,000 | +20.2% | 82,267 | -10.3% | 0.00% | – |
| Q3 2015 | $554,000 | -26.2% | 91,672 | +0.5% | 0.00% | – |
| Q2 2015 | $751,000 | +1.1% | 91,222 | -7.3% | 0.00% | – |
| Q1 2015 | $743,000 | +5.7% | 98,372 | -4.4% | 0.00% | – |
| Q4 2014 | $703,000 | +31.2% | 102,847 | -13.6% | 0.00% | – |
| Q3 2014 | $536,000 | -24.1% | 119,069 | -1.4% | 0.00% | – |
| Q2 2014 | $706,000 | -18.7% | 120,708 | -7.8% | 0.00% | – |
| Q1 2014 | $868,000 | +35.6% | 130,968 | +18.5% | 0.00% | – |
| Q4 2013 | $640,000 | -50.2% | 110,493 | -52.2% | 0.00% | – |
| Q3 2013 | $1,285,000 | -80.4% | 231,106 | -50.1% | 0.00% | -100.0% |
| Q2 2013 | $6,547,000 | – | 462,984 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |